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116 Effect of Staphylococcus aureus supernatant on airway
epithelium functionality in infants with cystic ﬁbrosis
K. Bessaci-Kabouya1,2, B. Gaultier2, J.-M. Zahm1, C. Coraux1, P. Mauran1,
L. Weiss2, M.-L. Dalphin2, J. Derelle2, A. Tatopoulos2, F. Huet2, S. Perez-Martin2,
P. Birembaut1, M. Abely1,2. 1INSERM U903, Reims, France; 2CF France East
Network, Besanc¸on, Dijon, Nancy, Strasbourg, Reims, France
Staphylococcus aureus colonizes very early the airways in CF patients. For a better
understanding of the physiopathological mechanisms which are involved in the ﬁrst
stages of CF lung disease development, we analyse the airway epithelium from
young asymptomatic CF infants.
The aim of the present work was to study the effect of Staphylococcus aureus toxins
on airway epithelium functionality.
Airway epithelial sheets collected from nasal brushings were analyzed for ciliary
beating frequency measurement, for assessment of chloride and potassium efﬂux
and for measurement of gap junction functionality.
In 13 CF infants diagnosed by neonatal screening and in 8 non-CF infants, nasal
brushing was performed within 6 months after birth and incubated or not with
S. aureus supernatant. Chloride efﬂux was signiﬁcantly (p< 0.04) decreased in
CF patients compared with non-CF patients. We also observed that S. aureus
supernatant signiﬁcantly decreased ciliary beating frequency (p< 0.02), chloride
efﬂux (p< 0.01), voltage-dependent potassium efﬂux (p< 0.02) and gap junction
functionality (p< 0.03) in non-CF and CF infants.
The present data demonstrate that, prior to any lung disease development in CF
infants, toxins produced by S. aureus may alter the functionality of the airway
epithelium and may favour the decline of pulmonary function in CF.
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117 Achromobacter xylosoxidans characteristics important for lung
colonization of cystic ﬁbrosis (CF) patients
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Objectives: Achromobacter xylosoxidans is an emerging pathogen increasingly
isolated from respiratory samples of CF patients, often associated to antibiotic
resistance. The present study was aimed to investigate virulent traits of 57 A. xylos-
oxidans strains isolated from CF patients and correlated the results with patients
forced expiratory volume in 1s (FEV1%).
Methods: 57 A. xylosoxidans strains were isolated from sputum samples of
CF patients attending at the Regional Centre of Cystic Fibrosis of the Umberto Iº
Hospital of Rome. We carried out a genomic characterization by randomly ampliﬁed
polymorphic DNA (RAPD) and evaluated A. xylosoxidans bioﬁlm production on
abiotic surfaces and antibiotic resistance. Resistance determinants were studied by
Polimerase Chain Reaction (PCR) in highly resistant strains.
Conclusion: Our results demonstrate the ability of A. xylosoxidans to transfer its
extended-spectrum b-lactamase-encoding plasmid. 7 A. xylosoxidans strains had the
speciﬁc band related to metal b-lattamase, and 3/7 of the them showed to possess
speciﬁc band of the integron1. All isolates showed to be bioﬁlm producer and
were divided in three classes. RAPD proﬁles resulted to be related to CF pathology
status (estimated by FEV 1% values). The ability to form bioﬁlms and the multidrug
resistance showed by A. xylosoxidans are certainly important factors inﬂuencing its
virulence degree and seems to be bacterial features important for the colonization
of CF patients with chronic infections and with more severe clinical conditions.
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Introduction and Objectives: Bacterial lipopolysaccharide (LPS), a major compo-
nent of the Gram-negative outer membrane, can elicit a potent response from the
innate immune system and is recognised by various host cell receptors. The aim of
this study was to characterise LPS from CF Prevotella isolates to provide insight
into the potential role of Prevotella LPS in CF respiratory disease.
Methods: LPS from 48 clinical isolates, representing 15 distinct species and 2
Prevotella type strains were characterised: Belfast isolates (n = 26), cultured from
CF sputum; North Carolina isolates (n = 7), cultured from sputum or BAL; UK non-
CF invasive isolates (n = 15). CF isolates were cultured from patients when clinically
stable (n = 29) or during pulmonary exacerbation (n = 4). LPS was extracted using
a micro-scale modiﬁcation of the phenol hot water method, and characterised via
Tricine SDS-PAGE and silver staining.
Results: LPS consisted solely of a lipid A-core oligosaccharide in 30/33 (91%) CF
isolates and 6/15 (40%) non-CF isolates. An additional higher molecular weight
LPS component was detected in 3/33 (9%) CF isolates and 9/15 (60%) non-CF
isolates.
Conclusions: Clinical CF Prevotella isolates have “rough type” LPS, consisting
solely of a lipid A-core oligosaccharide component. The absence of an outer
O-antigen component may inﬂuence macrophage recognition of Prevotella spp.
within the CF airways and result in a modiﬁed host immune response.
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In CF sputum anaerobic conditions prevail. Along with Pseudomonas aeruginosa
and obligate anaerobes, S. constellatus − a microaerophilic bacterium − can be
found. S. constellatus is detected in high bacterial numbers in 39% of CF lung exac-
erbations. We investigated the interaction between S. constellatus and P. aeruginosa
during anaerobic growth. P. aeruginosa strain PAO1 was incubated anaerobically
together with four S. constellatus patient strains diluted 100 to 10−8 fold. Colony
forming units (CFU) were determined after three days. Lactate production was
determined spectrophotometrically, the inﬂuence of lactate on P. aeruginosa growth
was investigated. P. aeruginosa growth is reduced by one order of magnitude in
the presence of all S. constellatus strains (2.9±1.5×109 vs 3.0±5.3×108 cfu/ml,
p< 0.005). S. constellatus growth in the presence of P. aeruginosa is increased by
one order of magnitude (4.5±3.2×107 vs. 7.7±2.5×108 cfu/ml, p< 0.001). All
S. constellatus strains diluted 10−7 fold could grow in a P. aeruginosa solution up
to comparable bacterial numbers although the bacteria by themselves would not
grow in this dilution. S. constellatus produces 22.0±0.3mmol/L lactate, but this
amount of lactate does not inﬂuence P. aeruginosa growth. S. constellatus beneﬁts
from P. aeruginosa by reaching increased cfu. P. aeruginosa oxygen consumption
may contribute to this fact. However, S. constellatus can also survive aerobically.
Thus, other mechanisms must explain the growth advantage. Even minute amounts
of S. constellatus succesfully infect a P. aeruginosa solution explaining why
S. constellatus easily may contaminate CF sputum.
